Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delayed BNT162b2 Schedule in Children
NCT05329064Phase 4Unknown
- Sponsor
- KK Women's and Children's Hospital
- Start
- Mar 2022
- Primary completion
- Dec 2023
- Modality
- Vaccines & Immunotherapeutics, Lipid-based Nanoparticles, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of tozinameran in coronavirus disease 2019 (COVID-19), sponsored by KK Women's and Children's Hospital. Status: unknown.
02
Drugs
tozinameran
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05329064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05329064.